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ABSTRACT
The absence of menstrual periods for one or more periods is called amenorrhea. Primary
amenorrhea means the lack of its occurrence until the age of 16 years. Secondary amenorrhea
refers to situations that a person has experienced menstruation periods in the past and then stops
its occurrence. Amenorrhea is a symptom, not a disease that can cause due to disorders of
hypothalamus and pituitary glands, disorders of sexual glands and deformities of the uterus and
ovaries. Due to the clinical importance of reproductive in life and non-reproductive of women
amenorrhea due to ovarian function, this study has been conducted in order to determine the
prevalence and type of chromosomal abnormalities in women referred to the Cytogenetic
Laboratory of Cellular and Molecular Research Center, in University of Medical Sciences of
Qazvin. Karyotype analysis and its relationship with phenotype were performed on 110 Iranian
female patients with primary and secondary amenorrhea. Metaphase chromosomes were
prepared and analyzed by G-banding technique and were evaluated to examine the mosaicism
of 100 cells of lymphocytes cells.
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Karyotype of 91 women (82.72%) was normal and chromosomal abnormalities in 19 patients
out of 110 patients (17.37%) were observed with primary and secondary amenorrhea. Primary
amenorrhea was observed in 17 of these patients, two of whom also had a secondary
amenorrhea. Monosomy chromosome X (6 Cases- 31.57%) and Monosomy chromosome Y (6
Cases- 31.57%) was the most common disorders observed in the women with primary
amenorrhea. Monosomy mosaic and trisomy chromosome X were observed in 2 cases of
women with secondary amenorrhea (21.81% of the whole statistical sample). The overall
prevalence of chromosomal abnormalities was between 15.9 % and 63.3% among patients with
primary amenorrhea, that our findings in chromosomal analysis of these women (19.76%)
confirm it.
Keywords: cytogenetic, primary amenorrhea, secondary amenorrhea, chromosomal
abnormalities.
1. INTRODUCTION
Primary amenorrhea or absence of menstrual periods occurs when a young girl still has not been
started her menstrual periods until age 16 and secondary amenorrhea occurs in women who
have menstrual periods and then it has been stopped [1; 2].
Primary amenorrhea less than is involved 1%  and secondary amenorrhea is involved around 5
to 7 percent of teenage girls in the United States .It should be noted that there is no evidence that
the incidence of amenorrhea varies according to the population and ethnic diversity[3].
The most common reasons of primary amenorrhea are disorders in the hypothalamus and
pituitary (27.8%), disorders of glands sexual / ovarian (50.4%), and genital and urinary
abnormalities (21.8%).Cytogenetic studies indicate the important role of chromosomal
abnormalities in creating of amenorrhea. [4; 5; 8; 6]
So, half the primary amenorrhea cases that are created by sexual glands /ovary disorders often
are created by abnormal sex chromosome (X). Usually sexual glands disorders are created by
especially the Turner syndrome (TS). But also amenorrhea is seen in sexual glands disorders
XX 46 and XY 46 (syndrome Swyer), or intersex disorders (insensitivity syndrome to complete
androgen of CAIS) and mixed sexual glands disorders (MGD). [7;3].
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In contrast most cases of secondary amenorrhea (SA) are created by chromosomal
abnormalities such as monosomy X or trisomy of chromosome XXX. [3]. The aim of this
retrospective analysis was to estimate the frequency of occurrence the chromosomal
abnormalities in women referred to the Cytogenetic Laboratory of Cellular and Molecular
Research Center, in University of Medical Sciences of Qazvin. All patients were evaluated
clinically and were evaluated with G-banding technique by cytogenetic method.
1.1. Research methodology
Peripheral blood samples were prepared from 110 women with primary and secondary
amenorrhea during the period December 2010 to November 2015, among women referred to
the Cytogenetic Laboratory of Cellular and Molecular Research Center, in University of
Medical Sciences of Qazvin. Inclusion criteria included confirmation of primary amenorrhea or
secondary amenorrhea (cessation of menstruation for more than 6 months).
To prepare slides of chromosomes of each person (karyotyping) was used method Rooney and
Czepulkowski [8] with changes. 2 ml of peripheral blood of each patient were collected in the
heparinized syringes. Of each sample ,10 drop of blood of patients were cultured with 5 cc of 20%
culture medium RPMI (GIBCO, UK), 2% solution of serum FBS (GIBCO, UK),1% PHA
(GIBCO, UK),  penicillin antibiotics mixture / streptomycin (GIBCO, UK)  in the sterile
media. Then it was incubated for 72 hours in a 37Cº incubator without CO2. Cell proliferation
with the addition of 1% volume of Kalsmyd (GIBCO, UK) was stopped after 72-hour culture.
During this period, cell culture was incubated for 20 minutes at 37Cº.
Then centrifuge and the supernatant solution from sedimentation of cells were removed and 10
cc of 37Cº KCL hypotonic solution for lysis of red blood cells added to it and was incubated for
20 minutes at 37 Cº. Then the cells were fixed and washed by fixative solution of acetic
acid-methanol (1: 3) (Merck, Germany) at laboratory temperature. Stabilization of slides was
performed for 3 times, each time after sediment of lymphocytes by centrifugation with a round
of rpm of 1200 for 10 minutes. At the end the solution containing white blood cells
(lymphocytes) must be colorless and clean, otherwise it can be repeated the fixation operation .
Finally, fixed cells were dropped on the slides. Slides were prepared to stain after drying.
Prepared slides were transported to lose their excess water at 37 Cº for a few days. Then each
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slide was placed first for 40-60 seconds at 37 Cº bonding solution (containing the solution 95%
Hanks (HBSS), containing 5% pancreatin (Sigma, Germany).
Immediately after washing each slide was placed in the first 37 Cº washing solution (containing
95% normal saline and 5% bovine serum FBS) for 40-60seconds and then at a laboratory
temperature in the second washing solution (containing 50 cc normal saline) for 7-8seconds.
Then each slide in the special staining box contains 3-5 percent Giemsa (Merck, Germany) was
stained for 4-5 minutes. Immediately after staining each slide was washed with distilled water,
dried at laboratory temperature and was studied by light microscopy (Cytovision, Applied
Imaging). At least 50 metaphases were evaluated for each patient and according to standard
protocols have band resolution of 400 to 450. Blood had been only studied tissue routinely.
That is why this study had been limited to blood analyzes. Data analysis was performed by
using Fisher test and was considered a significance level of 0.05%.
2. STAINING BOX
2.1. Findings
A number of 110 women entered to study with confirmation the 86 cases of primary
amenorrhea (78.2%) and 24 cases of (21.8%) secondary amenorrhea under 40 years old and
with FSH> 40mlU / ml. The mean age of the patients was 37.63. 17 women (19.76%) with
primary amenorrhea had abnormal karyotype. 6 patients (35.29%) were identified with
Monosomy chromosome X.
One patient (5.8%) was observed also with Monosomy X chromosome and Inversion of
chromosome 9. Inversion of chromosome 9 and chromosome X in the 2 patients (11.76%) were
observed. Isochromosome and remove part of the long arm of chromosome X, each one (5.8%)
was observed in one patient. 6 patients were detected also (35.29%) with karyotype, XY 46
with mixed sexual glands disorders (MGD) (Table 1).
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Table 1. Chromosomal abnormalities in 17 Patients with primary amenorrhea
Frequency Diagnosis Type of Chromosomal abnormalities
X chromosome homogenous monosomy
35.29% TS 45,X
5.8% TS 45,X,inv(9)(p11 q13)
X chromosome unbalanced structural abnormalities
5.8% TS 46,X,i(Xq)(q10:q10)
5.8% TS 46,X,del(Xq)(q13)
X chromosome balanced structural abnormalities
11.76% PA 46,XX, inv(9)(p11 q13)
46,XY sex-reversal syndrome
35.29% MGD 46,XY
Most abnormalities were observed in the patients with primary amenorrhea of Monosomy of
chromosome X, that all of these patients had clinical symptoms of Turner syndrome. Short
stature and delayed puberty and lack of incidence secondary sexual characteristics were of
important clinical symptoms of these patients. In one of these patients in addition to X
Monosomy, was observed the Inversion of chromosome 9 that the primary amenorrhea with
delay of puberty was reported of clinical symptoms of this patient. Inversion of chromosome 9
and chromosome X was detected in two other patients with clinical symptoms of primary
amenorrhea (Fig 1).
Fig.1. A: Karyotype:  46, XX, inv (9) (p11q13) an apparently normal female karyotype.
However one chromosome 9 had a pericentric inversion around centromere. This is usually
considered as a normal population variant. / B: Karyotype:  45, X, inv (9) (p11q13) A female
karyotype with only one X chromosome which is consistent with Turner syndrome. However,
one chromosome 9 had a pericentric inversion around its centrome.
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It should also be noted that patients of Monosomy of X chromosome with clinical symptoms of
Turner syndrome such as short stature, primary amenorrhea, the absence of secondary sexual
characteristics, showed high serum levels of LH and FSH. Two cases of these women with
Turner syndrome were developing to hypogonadism in addition to primary amenorrhea. Also,
in this study, long arm of chromosome X was detected in the Isochromosome disease and in
another disease, was detected the removal of part of the long arm of chromosome X (Fig 2).
Fig.2. A: Karyotype:  46,X,i(X)(qter→q10::q10→qter) An abnormal female karyotype with
an isochromosome for long arm of X chromosome./ B: Karyotype:  46,X,del(X)(q13) An
abnormal female karyotype with a deletion in the long arm of one X chromosome.
In addition, karyotypes of 6 persons (35.29%) of women with primary amenorrhea, XY 4 were
diagnosed that these women had clinical, variable symptoms and features and sexual glands
disorders.
Three cases of these women were sisters of 26 25.36 years old and had clinical symptoms of
primary amenorrhea, vaginal blind and testis inguinal, (Figure 3). However, by genealogy
analysis of this family, it became clear that there is no family history of developing to this
disease in the family of their father and mother. These sisters had also male sexual organ in
addition to primary amenorrhea and lack of sufficient growth of breast.
Other women referred with primary amenorrhea had small uterus and ovaries or deformities of
the uterus and genitals. In some women with primary amenorrhea that have normal karyotype
was observed mild mental retardation and behavioral problems and hypothyroidism. For
example, one of these women was 20-year-old girl that had hypothyroidism and mental
retardation in addition to primary amenorrhea. In addition, in the sonography, her uterus and
ovaries were reported small and were reported very high serum hormones of FSH and LH. It
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should be noted that the sister of this woman who had Turner syndrome, died in the age of 17.
Also two of these women had congenital malformations of cleft lip and palate that one of them
had chromosome 1Y (Mixed Gonadal Dysgenesis), but the other one was normal in terms of
karyotype.
In a study of women with secondary amenorrhea of 24 women, 22 (91.8%) had normal
karyotype, XX46 and 2 females (8.2%) of the women had abnormal karyotype (Table 2). These
women had Monosomy chromosomal mosaicism X ((8), XXX 47 / (22), X45) and ((45), XX 46
/ (5), X 45), that both of them had clinical symptoms of Turner syndrome (Fig 4) Of the 24
women who had secondary amenorrhea, 8 persons (33.3%) had experienced early menopause
that had high FSH and low  AMH.
Table 2. The karyotype results in patients with Secondary amenorrhea
FrequencyDiagnosisNo. of
cases
karyotype
91.8%SA2246,XX
4.1%TS145,X/46,XX
4.1%TS145,X/47,XXX
SA - Secondary amenorrhea; TS - Turner Syndrome
1. Mixed Gonadal Dysgenesis
Fig.3. Family tree of three Sisters who had karyotype , XY 46 with symptoms of primary
amenorrhea, vaginal blind and testis inguinal
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Fig.4. A: Karyotype: 46, XX [45] / 45, X [5]: 50 cells were screened. Two cell lines were
observed. 45 cells (90%) were Normal 46, XX and 5 cells (10%) of cells were 45, X. /B:
Karyotype: 45, X [22] / 47, XXX [8]: 30 cells were screened. Two different cell lines were
observed.  One cell line was 45, X (73%) and the other cell line was 47, XXX (27%).
Table3. Chromosomal abnormalities detected in cases with primary amenorrhea in
different studies
karyotype Present
study
Butnariu
et al (3)
Wong
et al
(23)
Kong
et al
(10)
Vijayalaksmi
et al (21)
Kalavathi
et al (9)
Ramirez
et al (6)
Safaei
et al(1)
Frequency
of
abnormal
karyotype
(number
of cases)
19.76%
(17)
54.56%
(269)
24.5
%
(58)
58.8
%
(10)
27.8%
(39)
25.82%
(220)
36.7%
(96)
20%
(44)
X
chromoso
me
41.17%
(7)
82.15%
(221)
50%
(29)
20%
(2)
74%
(29)
45.45%
(100)
89.58%
(92)
52.27%
(23)
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(homogen
eous/mosa
ics)
aneuploidi
es
X
chromoso
me
unbalance
d
structural
abnormalit
ies
11.76%
(2)
8.17%
(22)
12.06
%
(7)
50%
(5)
8.69%
(3)
27.27%
(60)
4.16%
(4)
15.90%
(7)
Marker
chromoso
me
- - 1.72
%
(1)
- - - - -
Mosaics
X/XY and
variants
- 3.34%
(9)
1.72
%
(1)
- - 3.63%
(8)
- 4.54%
(2)
46,XY 35.29%
(6)
5.20 %
(14)
8.4%
(20)
30%
(3)
17.9%
(7)
23.63%
(52)
7.85%
(3)
27.27%
(12)
Other
anomalies
11.76%
(2)
1.11%
(3)
- - - 7.23% - -
In the previous conducted studies the most common causes of amenorrhea was Turner
syndrome, which has been reported in various forms including: 45, X (45%), 45, X / 46, XX
(13%), 45, X / 46, X, i (Xq ) (8%), (46, X, i (Xq (7%) and 45 X / 46XY (7%).
Although in most cases there is a relationship between these reported karyotype and patients
of Turner syndrome but it must be remembered that only based on phenotypic characteristics
associated with Turner cannot predict definitely the karyotype of Turner syndrome.
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After Monosomy of chromosome X, the most frequent abnormal karyotype (6 –
cases ,35.29%) in women with primary amenorrhea, was reported the monosomy karyotype of
chromosome Y (, XY 46). These patients had different clinical symptoms such as Gene mixed
sexual glands dysfunction, vaginal blind and primary amenorrhea and lack of maturing
secondary sexual characteristics.
In previous studies, the frequency of male karyotype for women with primary amenorrhea has
been reported from 3.3% percent to 13.7% that results obtained in this study are higher than
reported cases in previous studies.
The last group of abnormalities identified in patients with primary amenorrhea, are
non-balanced structural abnormalities (2 cases-11.76%) and a balanced structural
abnormalities (1Case -5.8%).
In patients with secondary amenorrhea, women with normal karyotype showed higher
frequency(91.8%) that can be said most cases of incidence secondary amenorrhea In them is
due to glands disorders of the hypothalamus and pituitary [3;2]. Frequency of chromosomal
abnormalities in women with secondary amenorrhea was observed 8.2% (2cases of 24 cases).
The percentage of frequency of chromosomal abnormalities in women with secondary
amenorrhea of 3.8% to 16.32% has been reported very different. The obtained results in our
study were matched like studies with frequency of abnormal karyotype (9/9%) [9]and the
frequency (7.08%) observed in another study [10].
In contrast the percentage of frequency of abnormal karyotype in women with secondary
amenorrhea in other similar studies with a frequency between 13.3% and 44.4% [11; 12; 13; 4;
14], have reported higher than the results of our study (table 4).
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Table 4. Chromosomal abnormalities detected in cases with secondary amenorrhea in
different studies
Karyotype
results
Present
study
Butnariu
et al(3)
Wong
et al
(23)
Lin
et al
(11)
Rajangam
et al(16)
Kalavathi
et al (9)
Daevi
et al(5)
Optiz
et al(15)
No. of Cases 24 38 312 18 245 127 30 15
46,XX 22 31
(81.57%)
281
(90.1%)
10
(55.6%)
215
(87.75%)
118
(92.91%)
26
(86.7%)
10
(66.7%)
Abnormal
karyotype
- 7
(18.42%)
31
(9.9%)
8
(44.4%)
40
(16.32%)
9
(7.08%)
4
(13.3%)
5
(33.3%)
45,X - - 5
(1.6%)
3
(16.6%)
- 1
(0.79%)
- -
X monosomy
mosaic
2 7
(18.42%)
11
(3.5%)
2
(11.1%)
20
(8.32)
8
(6.77%)
4
(13.3%)
-
46, del (Xq) - - 6
(1.9%)
- - 5
(4.23%)
1
(3.3%)
-
46,X,i(Xq) - - 1
(0.3%)
- 7
(2.85%)
3
(2.54%)
1
(3.3%)
-
t (X;A) - - 2
(0.6%)
1
(5.5%)
- - 2
(6.6%)
-
47,XXX - - 3
(1%)
2
(11.1%)
3
(7.5%)
1
(0.79%)
- -
46,XX/47,XXX - - 3
(1%)
- 10
(4.65%)
- - -
Finally in the cytogenetic and clinical evaluation of all patients with primary and secondary
amenorrhea in this study (19 cases-17.27%) (12cases -10.9%) had of these women with
Turner Syndrome or Turner mosaicism (Table 1 and 2). These patients developed Turner
syndrome due to errors occurred during mitotic divisions after fertilization, that are leading to
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the removal or absence of the long arm of chromosome X (Xq13-q28)[15].
According to this hypothesis, patients with long arm isochromosome X and or monosomy of
short arm of chromosome X with clinical signs such as short stature, Infantilism and sexual
glands disorders are along with other congenital abnormalities. On the other hand, patients
with X chromosome elimination especially in area (Xq13-q26), who have primary
amenorrhea that is due to ovarian disorder [15;16].
In fact, many genes that are essential in the development and or ovarian function, on the long
arm of the X chromosome.  Inactivation center of X chromosome turns off in the
rearrangement of chromosomal in the region Xq13. It is possible that X rearrangements and
autosome do not create the interference in the genes that affect ovarian function, but these
rearrangements can be due to effect of place cause to change the expression [17]. Existence of
isochromosom Xq suggests the increase the risk of developing to hypothyroidism and
inflammatory bowel disease [16;18].
Patients with monosomy of Y chromosome have been reported with different clinical
symptoms, that in this study were the patients with mixed sexual glands disorders that the best
advice for these patients is the removal of these sexual glands to prevent them from getting to
Gonadoblastom because these are people with increased risk of developing to Gonadoblastom
[19;18].
Furthermore, although patients with trisomy or X chromosome mosaicism do not seem that
have clear clinical signs for cytogenetic studies, but should know that chromosome study of
these people can lead to a better understanding of the cause of occurrence the amenorrhea In the
these people.
On the other hand chromosomal abnormalities in patients with secondary amenorrhea in this
study had a lower frequency (2 cases-8.3%), which are nearly similar to other studies which
indicate this matter that the various factors other than chromosomal abnormalities can be
involved in this matter. In the cases of primary and secondary amenorrhea balanced and
lopsided numerical and structural changes of sex chromosome and chromosomal mosaic show
a significant relationship with the development of the ovaries and Gonadogenes.
Therefore, in this study also like other previous conducted studies the relationship between
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primary and secondary amenorrhea and Chromosomal anomalies were confirmed (p <0.05)
that due to the low number of studied women and lack of the breadth of selection criteria of
these women, chromosome study the women with primary and secondary amenorrhea, with
larger sample sizes and inclusion criteria to more specialized study as a significant cause of
infertility leads to a better understanding of its causes and offering the related solutions.
Also, in spite of chromosomal abnormalities in patients with primary and secondary
amenorrhea, genetic counseling along with hormone therapy, and other treatment methods are
essential for fertility.
Although people with Turner syndrome are suffering from primary infertility, clinical and
genetically advice can be very important for people with secondary amenorrhea that are prone
to early menopause and also people with mixed sexual glands disorders who have increase the
risk of developing to Gonadoblastom
Therefore, performing the cytogenetic tests and genetic counseling are recommended before
any action. It should also be noted that the information obtained from cytogenetic tests such as
chromosomal analysis are important for management of patient, genetic counseling and future
plans of individual.
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